Two Epidemics. One Mission.
How We Do It.
HIV and Tuberculosis (TB) are the world’s two most deadly infectious diseases. Additionally, these two epidemics are tragically interconnected, as TB is the leading cause of death for those living with HIV.
At the Division of Global HIV & TB (DGHT), we are tackling these two epidemics to produce the greatest impact. DGHT experts are working on the front lines in more than 45 countries and regions around the globe, focused on a single mission: to fight these diseases and, ultimately, bring an end to the dual epidemics of HIV and TB worldwide.
What We Do
Worldwide, HIV and TB are a deadly combination.
CDC and partners are making a powerful impact
against these two diseases.
*Other USG agencies may have also contributed
**As of Sept 30, 2017
***FY2017 | ****Cumulative through Sept 30, 2017
Men have received voluntary medical circumcision procedures****
People who received a positive HIV test result***
Men, women and children who have received life-saving HIV treatment**
Screened in Care for TB***
Women who were treated to help reduce
risk of mother-to-child HIV transmission***
Antiretroviral Treatment for
PEPFAR: 13.3 Million
CDC: 7.3 Million
Antiretroviral Treatment to
Prevent Mother-to-child Transmission***
Voluntary Medical Male Circumcisions
PEPFAR: 15.2 Million
CDC: 7.5 Million
HIV-Positive Persons Screened in Care for TB***
PEPFAR: 7 Million
CDC: 4.7 Million
People Who Received a
Positive HIV Test Result***
PEPFAR: 3.3 Million
CDC: 1.8 Million
*Other USG agencies may have also contributed to some of these achievements **As of Sept 30, 2017 ***FY2017 ****Cumulative through Sept 30, 2017
- Page last reviewed: November 26, 2018, 02:50 PM
- Page last updated: November 26, 2018, 02:50 PM
- Content source: